IR-MED's AI-Powered Infra-Red Spectrographic Decision : vima

IR-MED to file for FDA approval Q4 2023 with U.S. market launch expected in H1 20242.5 million patients develop pressure injuries and 60,000 die annually...

Related Keywords

Israel , Israeli , Oded Bashan , Rosh Pina , Petah Tikva , Yaniv Cohen , Sharon Levkoviz , Rabin Medical Center , Company Annual Report On Form , Beit Rivka Hospital , Science Officer , Private Securities Litigation Reform Act , Risk Factors , Annual Report , Chief Financial , Other Otc Irme , Vr Med , Nc , R Med Inc , Tcqb Irme , Non Invasive Device , Ressuresure , Healthcare Profession ,